1 / 2

UCLA Comprehensive Atherosclerosis Treatment Program Medication Goals

Front. Back. UCLA Comprehensive Atherosclerosis Treatment Program Medication Goals All patients with coronary, other vascular disease, or diabetes treated with aspirin and/or clopidogrel*

zofia
Download Presentation

UCLA Comprehensive Atherosclerosis Treatment Program Medication Goals

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Front Back • UCLA Comprehensive Atherosclerosis • Treatment Program Medication Goals • All patients with coronary, other vascular disease, or diabetes treated with aspirin and/or clopidogrel* • All patients with coronary, other vascular disease, or diabetes treated with a statin* (dosed to achieve LDL < 100 mg/dl) • All patients with coronary, other vascular disease, or diabetes treated with an ACE inhibitor* • All patients with coronary, other vascular disease, or diabetes treated with a beta blocker* • * unless contraindicated, not tolerated, or reason for • not using documented in the medical record • Achieve Targets • LDL < 100 mg/dl, HDL > 40 mg/dl • BP < 140/90 mmHg • Smoking Cessation • LDL Treatment to Goal Guide • Baseline % reduction to goal • LDL Levelof LDL < 100 mg/dl • 115 mg/dl 13% • 120 mg/dl 17% • 125 mg/dl 21% • 130 mg/dl 24% • 140 mg/dl 29% • 150 mg/dl 34% • 160 mg/dl 38% • 170 mg/dl 42% • 180 mg/dl 45% • 190 mg/dl 48% • SimvastatinLovastatin Atorvastatin • 10 mg 22% 10 mg 22% 10 mg 34% • 20 mg 31% 20 mg 25% 20 mg 41% • 40 mg 38% 40 mg 31% 40 mg 48% • 80 mg 45% 80 mg 41% 80 mg 51% • PravastatinFluvastatin • 10 mg 22% 20 mg 20% • 20 mg 27% 40 mg 27% • 40 mg 32% 80 mg 32% • 80 mg 37% • Visit www.med.ucla.edu/champ for further details •  2002 CHAMP, UCLA Division of Cardiology

  2. UCLA Critical Pathway Overview for UA/NSTEMI Unstable Angina/ Non–ST-elevation MI* ASA, Clopidogrel, -blockers, ACEI, statin Heparin or LMWH ECG + and/or cTnI + Troponin - Conservative Strategy Invasive Strategy Rest pain 6hr cTnI - / ECG- GPIIb/IIa RA + DC home or ETT Hour 8-12 Cath/PCI Hour (0-6) D/C Day hour 18-24 D/C home hour 8-16 ASA, Clopidogrel, -blockers, ACEI, statin

More Related